NCT05038735 2026-02-20
EPIK-B5
Novartis
Phase 3 Active not recruiting
Clinical Trials
6 trialsNCT04251533 2026-02-13
EPIK-B3
Novartis
Phase 3 Active not recruiting
NCT05501886 2026-02-10
VIKTORIA-1
Celcuity Inc
Phase 3 Active not recruiting
NCT05646862 2026-02-05
INAVO121
Hoffmann-La Roche
Phase 3 Active not recruiting
NCT04208178 2026-02-02
EPIK-B2
Novartis
Phase 3 Active not recruiting
NCT05063786 2025-09-08
ALPHABET
Spanish Breast Cancer Research Group
Phase 3 Active not recruiting